Company Overview of Eleven Biotherapeutics Inc.
Eleven Biotherapeutics Inc., a biopharmaceutical company, engineers and develops protein-based therapeutics to improve human health and treat diseases. It offers EBI-005, a topically administered IL-1 protein for the treatment of ocular diseases. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.
215 First Street
Cambridge, MA 02142
Founded in 2008
Key Executives for Eleven Biotherapeutics Inc.
Eleven Biotherapeutics Inc. Key Developments
Similar Private Companies By Industry
|Genaera Corp.||United States|
|Critical Biologics Corporation||United States|
|Alcon Holdings, Inc.||United States|
|Atterocor, Inc.||United States|
|Theradigm, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- East Township, NY | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Eleven Biotherapeutics Inc., please visit www.elevenbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.